/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $138.8 billion, Boston Scientific Corporation (BSX) is a global medical device company that develops, manufactures, and markets innovative technologies across interventional medical specialties, operating through its MedSurg and Cardiovascular segments. It provides advanced solutions for gastrointestinal, urological, neurological, cardiovascular, and cancer-related conditions worldwide.
Shares of the Marlborough, Massachusetts-based company have underperformed the broader market over the past 52 weeks. BSX stock has decreased 8.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 15%. Moreover, shares of the company have declined 1.6% on a YTD basis, compared to SPX's 1.9% return.
